Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Glaucoma, Basic & Translational Research

Move Out of the Tunnel… and into the Light!

I believe metabolomics has the potential to shed light into the pathophysiology behind glaucomatous damage, as well as providing potential biomarkers for early glaucoma detection.

Metabolomics is the detailed study of metabolites created by the cellular processes in an organism. Influenced by both genetic and environmental factors, the metabolite profile gives us a “fingerprint” of the health status of the organism at the time of sampling. But aside from disease mechanisms and biomarkers, this technology has also been increasingly used for drug target discovery and the prediction of drug effects – and it can help move medical care towards a more personalized approach.

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login as a Guest or via Social Media

About the Author

João Barbosa-Breda

João Barbosa-Breda is a Glaucoma Fellow, at the Ophthalmology Research Group of the KU Leuven (University of Leuven), Belgium

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register